Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
paraproteinemias/obesitat
L'enllaç es desa al porta-retalls
Pàgina 1 des de 17 resultats
Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Interleukin-6 (IL-6) and C-reactive protein (CRP, a surrogate marker for IL-6) are important in monoclonal gammopathy of undetermined significance (MGUS) and myeloma. Smoking and obesity may elevate CRP levels, while statins decrease CRP levels. A case-control study in 200 MGUS patients found that
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Obesity and black race have been associated with excess risk of multiple myeloma. The association of obesity with monoclonal gammopathy of undetermined significance (MGUS) is unknown. Further, it is not known whether the increased risk of multiple myeloma and MGUS in blacks is related to
Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Multiple myeloma (MM) is one of the most common hematologic malignancies in the United States and is consistently preceded by monoclonal gammopathy of undetermined significance (MGUS). This study investigates the role of obesity in the progression of MGUS to MM.
A retrospective identified cohort of
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
All multiple myeloma (MM) cases are preceded by the premalignant state monoclonal gammopathy of undetermined significance (MGUS). Results from previous studies show a positive association between obesity and MM; however, the association between obesity and MGUS is controversial. The aims were to
Coexistence of papular mucinosis and systemic amyloidosis associated with lambda-type IgD paraproteinemia.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The patient is an obese, 55-year-old woman. She noticed purpura at several sites when she was 49 years old. She visited our clinic with a chief complaint of exertional dyspnea at 51 years of age. Physical examination revealed localized edema in the left chest wall and lower abdomen with translucent
Reappraisal of risk factors for monoclonal gammopathy of undetermined significance.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A number of epidemiologic studies have demonstrated associations between obesity and diabetes and the risk of monoclonal gammopathy of undetermined significance (MGUS). However, since MGUS is an asymptomatic condition we evaluated whether these are true associations or the result of detection-bias.
Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Higher body mass index and adiposopathy have been associated with increased risk of hematologic malignancies such as leukemia, multiple myeloma, myeloproliferative disorders, Hodgkin's and non-Hodgkin's lymphoma, and myelodysplastic syndromes. Adiponectin is a multimeric protein of the white adipose
Geriatrics: a selected up-to-date bibliography.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This is the second annual revision of the Geriatrics Bibliography. Approximately two thirds of the old references have been replaced by more current or more detailed articles. The bibliography has been expanded to include several additional topics and over 200 new references. Since the literature
Necrobiotic xanthogranuloma presenting as a solitary tumor.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We report on a 60-year-old overweight white woman who presented with an asymptomatic flat, hard, yellow-brown subcutaneous plaque on her right hip. A total excision was performed. Histopathologic examination showed all the major features of a necrobiotic xanthogranuloma (NX) involving the entire
An update on molecular biology and drug resistance mechanisms of multiple myeloma.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Multiple myeloma (MM), a neoplasm of plasma cells, is the second most common hematological malignancy. Incidance rates increase after age 40. MM is most commonly seen in men and African-American population. There are several factors to this, such as obesity, environmental factors, family history,
Epidemiology of the plasma-cell disorders.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This review of the plasma-cell disorders begins with the definition of monoclonal gammopathy of undetermined significance (MGUS). The prevalence of MGUS in white and black populations is described. MGUS is a common finding in the medical practice of all physicians, and thus it is important to both
Scleredema adultorum of Buschke: an under recognized skin complication of diabetes.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Scleredema of Buschke or scleredema diabetorum is a skin complication of diabetes with deposits of collagen and aminoglycans in the dermis. This disease characterized by thickening and hardening of the skin, is usually localized in nape, back and shoulder areas. Consequences could be a decrease in
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
An increased risk of multiple myeloma (MM) has been observed among individuals with low prediagnostic circulating levels of adiponectin, a metabolic hormone that is typically underexpressed among those with overweight or obesity. To assess whether adiponectin may influence myeloma development or
Multiple myeloma: a review of the epidemiologic literature.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Multiple myeloma, a neoplasm of plasma cells, accounts for approximately approximately 15% of lymphatohematopoietic cancers (LHC) and 2% of all cancers in the US. Incidence rates increase with age, particularly after age 40, and are higher in men, particularly African American men. The etiology is
Light Chain Amyloidosis Presenting as Bilateral External Auditory Canal Obstructing Masses.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
: A morbidly-obese 57-year-old diabetic and hypertensive man with chronic kidney disease, diastolic heart failure, and bilateral hearing loss was found to have soft tissue masses/densities in the lateral aspect of both auditory canals on local examination and on imaging. He underwent biopsies of
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
